epirubicin has been researched along with Weight Gain in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (75.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Beckmann, MW; de Gregorio, N; Fasching, PA; Fehm, T; Friedl, TWP; Harbeck, N; Jäger, B; Janni, W; Jückstock, J; Mahner, S; Mohrmann, S; Mutschler, NS; Rack, B; Salmen, J; Schochter, F; Scholz, C; Weissenbacher, T; Widschwendter, P; Ziegler, C; Zwingers, T | 1 |
Amy, JJ; Coomans, D; Michielsen, D; Storme, G; Wyndaele, JJ | 1 |
Cheong, K; Chrystal, K; Forshaw, MJ; Gossage, JA; Harper, PG; Mason, RC | 1 |
Lankester, KJ; Lawton, PA; Phillips, JE | 1 |
2 trial(s) available for epirubicin and Weight Gain
Article | Year |
---|---|
Prognostic Impact of Weight Change During Adjuvant Chemotherapy in Patients With High-Risk Early Breast Cancer: Results From the ADEBAR Study.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Disease-Free Survival; Docetaxel; Epirubicin; Female; Fluorouracil; Follow-Up Studies; Germany; Humans; Kaplan-Meier Estimate; Mastectomy; Middle Aged; Neoplasm Staging; Prognosis; Prospective Studies; Weight Gain; Weight Loss | 2018 |
Symptomatic responses to neoadjuvant chemotherapy for carcinoma of the oesophagus and oesophagogastric junction: are they worth measuring?
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Decision Making; Deglutition; Disease Progression; Epirubicin; Esophageal Neoplasms; Esophagogastric Junction; Female; Fluorouracil; Humans; Male; Middle Aged; Neoadjuvant Therapy; Treatment Outcome; Weight Gain | 2006 |
2 other study(ies) available for epirubicin and Weight Gain
Article | Year |
---|---|
Mitomycin C and epirubicin: functional bladder damage in rats after repeat intravesical instillations.
Topics: Administration, Intravesical; Animals; Antibiotics, Antineoplastic; Epirubicin; Female; Mitomycin; Rats; Rats, Wistar; Urinary Bladder; Urodynamics; Weight Gain | 2005 |
Weight gain during adjuvant and neoadjuvant chemotherapy for breast cancer: an audit of 100 women receiving FEC or CMF chemotherapy.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cisplatin; Cyclophosphamide; Epirubicin; Female; Fluorouracil; Humans; Methotrexate; Middle Aged; Weight Gain | 2002 |